1. Soudijn W, Van Wijngaarden I, Janssen PAJ. US Patent no 4,031,226, 1977.
2. Rombaut N, Depoorter H, Brugmans J. Halopemide, a new potent non-neuroleptic dopamine-blocker with psychotropic properties. Communication at the XIth CINP Congress, Vienna (Austria), July 9–16, 1978.
3. Wauters A, Rombaut N. R 34 301 in the treatment of schizophrenia. An open pilot trial in 10 patients. Janssen Clinical Research Report R 34301/3. Beerse: Janssen Pharmaceutica, 1976.
4. Deberdt R. Anti-autistic properties of halopemide in the treatment of young oligophrenic patients with severe contact disturbances. A double-blind trial in 10 patients. Janssen Clinical Research Report R 34301/1. Beerse: Janssen Pharmaceutica, 1977.
5. Veltkamp BP. Halopemide in the treatment of infantile autism. A case study. Janssen Clinical Research Report R 34301/4. Beerse: Janssen Pharmaceutica, 1977.